Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Breier

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Brain Imaging and Behavior|September 7, 2020
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophreniaMichael M Francis, Tom A Hummer, Emily Liffick, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2007
Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal populationRalph E Hoffman, Scott W Woods, Keith A Hawkins, et al.
Journal of the American Medical Directors Association|January 7, 2004
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United StatesPeter D Feldman, Linda K Hay, Walter Deberdt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaWalter G Deberdt, Maurice W Dysken, Stephen A Rappaport, et al.
Journal of Abnormal Psychology|August 31, 2011
Temporal discounting of rewards in patients with bipolar disorder and schizophreniaWoo-Young Ahn, Olga Rass, Daniel J Fridberg, et al.
Brain Imaging and Behavior|March 10, 2015
Functional neuroanatomical correlates of episodic memory impairment in early phase psychosisMichael Matthew Francis, Tom A Hummer, Jenifer L Vohs, et al.
The Journal of Nervous and Mental Disease|April 23, 2015
Metacognitive capacity as a predictor of insight in first-episode psychosisJenifer L Vohs, Paul H Lysaker, Emily Liffick, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophreniaIstvan Bitter, Martin R K Dossenbach, Shlomo Brook, et al.
The American Journal of Psychiatry|June 4, 2002
Olanzapine versus divalproex in the treatment of acute maniaMauricio Tohen, Robert W Baker, Lori L Altshuler, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Brain Imaging and Behavior|September 7, 2020
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophreniaMichael M Francis, Tom A Hummer, Emily Liffick, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2007
Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal populationRalph E Hoffman, Scott W Woods, Keith A Hawkins, et al.
Journal of the American Medical Directors Association|January 7, 2004
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United StatesPeter D Feldman, Linda K Hay, Walter Deberdt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaWalter G Deberdt, Maurice W Dysken, Stephen A Rappaport, et al.
Journal of Abnormal Psychology|August 31, 2011
Temporal discounting of rewards in patients with bipolar disorder and schizophreniaWoo-Young Ahn, Olga Rass, Daniel J Fridberg, et al.
Brain Imaging and Behavior|March 10, 2015
Functional neuroanatomical correlates of episodic memory impairment in early phase psychosisMichael Matthew Francis, Tom A Hummer, Jenifer L Vohs, et al.
The Journal of Nervous and Mental Disease|April 23, 2015
Metacognitive capacity as a predictor of insight in first-episode psychosisJenifer L Vohs, Paul H Lysaker, Emily Liffick, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophreniaIstvan Bitter, Martin R K Dossenbach, Shlomo Brook, et al.
The American Journal of Psychiatry|June 4, 2002
Olanzapine versus divalproex in the treatment of acute maniaMauricio Tohen, Robert W Baker, Lori L Altshuler, et al.
Pageof 11